Angiogenesis occurs with contribution from VEGF and its receptors, eNOS and EGR-1, all of which have been shown to be affected and upregulated by BPC-157 [8, 38, 39, 7072]
Using these for your clients is risky and can get you in real trouble
Act 3: The Stacking Question What Longevity Experts Say About Combining Both The most sophisticated practitioners in the longevity space don't typically ask, "Should I use GLP-1 or BPC-157?" Instead, they ask, "When does each one belong in a protocol, and can they safely coexist?" The Complementary Logic Longevity-focused physicians and sports medicine practitioners have begun articulating a clear rationale for combining these compounds in specific patient profiles: The GLP-1 Layer: Addresses the metabolic side (reducing fat, improving insulin, lowering cardiovascular risk)
We do not perform diagnostic blood tests at CoLaz, and a private injection on top of an untested deficiency picture is not the right starting point